Interviews - Psychedelic Alpha

Our 2022 Year in Review is now live.

Interviews with the psychedelic sector’s leading Companies, organisations and individuals.

Read more about the article Interview | Elliot Marseille, Global Initiative for Psychedelic Science Economics (GIPSE)

Interview | Elliot Marseille, Global Initiative for Psychedelic Science Economics (GIPSE)

Post published:November 14, 2022
Post category:Interview

Read more about the article Interview | George Tziras, Small Pharma

Interview | George Tziras, Small Pharma

Post published:October 4, 2022
Post category:Interview

Read more about the article Interview | Josh Ismin, Psylo

Interview | Josh Ismin, Psylo

Post published:August 19, 2022
Post category:Interview

Read more about the article Interview: Dr. Josh Woolley (TrPR) and Ben Lightburn (Filament Health)

Interview: Dr. Josh Woolley (TrPR) and Ben Lightburn (Filament Health)

Post published:June 22, 2021
Post category:Interview

Read more about the article Thomas B. Roberts: “Psychedelic Directions, Where Does Your Mind Alight?”

Thomas B. Roberts: “Psychedelic Directions, Where Does Your Mind Alight?”

Post published:April 19, 2021
Post category:Interview

Read more about the article Nakul Raval, Researcher at the Neurobiology Research Unit, Copenhagen University Hospital

Nakul Raval, Researcher at the Neurobiology Research Unit, Copenhagen University Hospital

Post published:January 16, 2021
Post category:Interview

Read more about the article James Kuo, CEO and Co-founder of Tryp Therapeutics

James Kuo, CEO and Co-founder of Tryp Therapeutics

Post published:January 15, 2021
Post category:Interview

Read more about the article Jackie von Salm, Co-founder and CSO at Psilera Bioscience

Jackie von Salm, Co-founder and CSO at Psilera Bioscience

Post published:December 17, 2020
Post category:Interview

Read more about the article Lars Wilde, Co-founder of COMPASS Pathways

Lars Wilde, Co-founder of COMPASS Pathways

Post published:December 13, 2020
Post category:Interview

Read more about the article Andrew Chadeayne, Founder and CEO of CaaMTech

Andrew Chadeayne, Founder and CEO of CaaMTech

Post published:December 10, 2020
Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.